These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 553752)

  • 21. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
    Peduzzi L; Cozzi E
    Minerva Med; 1983 Feb; 74(6):249-54. PubMed ID: 6338419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A; Carletta C
    Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
    Giorcelli G; Vacha G; Icardi GP
    Proc Eur Dial Transplant Assoc; 1980; 17():367-71. PubMed ID: 7243794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drugs in hyperlipidemia].
    Stuyt PM
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relationship between the manifestation of diabetes and the treatment of hyperlipemia].
    Vogelberg KH
    Verh Dtsch Ges Inn Med; 1978; (84):1178-81. PubMed ID: 741921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological treatment of primary hyperlipoproteinemia].
    Ciświcka-Sznajderman M
    Pol Tyg Lek; 1976 Feb; 31(7):289-91. PubMed ID: 768941
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of hyperlipidemia].
    Müller G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 35. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K; Witanowska A
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy of dyslipidemias].
    Lenzi S
    Minerva Med; 1975 Oct; 66(66):3479-82. PubMed ID: 1178140
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ; Metz G; Specker M
    Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antilipemic agents--long term therapy and tolerance].
    Siegel C
    Med Welt; 1973 Apr; 24(14):544-6. PubMed ID: 4634140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 40. Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Trans Am Clin Climatol Assoc; 1968; 79():216-28. PubMed ID: 5760587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.